Danone's China Sales Expected to Drive Growth as U.S. Performance Lags -- Earnings Preview

Dow Jones
2025/10/24

By Aimee Look

 

Danone is scheduled to report results for the third quarter on Tuesday. Here is what you need to know.

 

SALES FORECAST: The French food company, which makes Activia yogurt and Evian water, is expected to report a increase in sales for the third quarter to 6.87 billion euros ($7.98 billion) from 6.83 billion euros for the same quarter a year earlier, according to an analyst consensus compiled by the company. Like-for-like sales are anticipated to grow 4.3%, made up of a 3% rise in volume/mix--or amount and variety of goods sold--and a 1.4% rise in prices, the analyst consensus compiled by the company shows. In the third quarter of last year, sales increased 4.2%.

 

Shares in Danone gained around 20% since the start of the year through Thursday's close, and rose 6.9% during the third quarter.

 

WHAT TO WATCH

 

--CHINA: There is a sizeable opportunity in China for Danone's medical-nutrition portfolio, analysts at Barclays wrote in a note. The analysts said they have been bullish on Danone China for a while, calling it the best-positioned stock in Europe to take advantage of the country's Healthy China 2030 initiative, and amid the country's aging population and regulatory change. Danone has recently expanded its medical-nutrition factory in the city of Wuxi, in eastern China, a sign of its confidence, the analysts said. UBS analysts said momentum in the country for infant milk formula also remains strong, and the specialized nutrition category overall is Danone's key growth engine.

--U.S.: U.S. organic growth and market share is under pressure for Danone, and yogurt remains particularly uninspiring in terms of volume growth, analysts at Bank of America said in a note. Growth for the category is decelerating quickly, while creamer sales volumes remain in decline, and plant-based product volumes disappoint, the analysts said. The company's products are losing market share in the U.S., with the analysts noting that its products have lower shelf lives than local competitors. In Europe, the company's market share is also under pressure, the Bank of America analysts added.

 

Write to Aimee Look at aimee.look@wsj.com

 

(END) Dow Jones Newswires

October 24, 2025 05:43 ET (09:43 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10